Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other neoplasm 1

Conditions

Precancerous Conditions 145Lymphoma 34Leukemia 32Multiple Myeloma 31Neoplasms, Plasma Cell 30Monoclonal Gammopathy of Undetermined Significance 30Lymphoma, Non-Hodgkin 29Lymphoma, Mantle-Cell 29Lymphoma, Large-Cell, Immunoblastic 29Lymphoma, Large B-Cell, Diffuse 29Lymphoma, Follicular 29Leukemia, Lymphocytic, Chronic, B-Cell 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Lymphoma, B-Cell, Marginal Zone 28Burkitt Lymphoma 28Immunoglobulin Light-chain Amyloidosis 27Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 26Hodgkin Disease 26Waldenstrom Macroglobulinemia 25Myeloproliferative Disorders 25Immunoblastic Lymphadenopathy 25Myelodysplastic Syndromes 24Lymphoma, Large-Cell, Anaplastic 24Leukemia, Hairy Cell 24Thrombocythemia, Essential 23Primary Myelofibrosis 23Leukemia, Myeloid, Acute 23Leukemia, Large Granular Lymphocytic 23Lymphoma, T-Cell, Cutaneous 22Leukemia, Prolymphocytic 22

Interventions

ON 01910 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Malignant Neoplasmas × Other neoplasm × Clear all
NCT01125891 2017-06-23

Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors

Traws Pharma, Inc.

Phase 1 Completed
39 enrolled
Other neoplasmOther solid neoplasm

Malignant Neoplasmas

Data powered by HemOnc (CC BY 4.0) Colophon âš¡